Gilead Sciences Inc at Jefferies Healthcare Conference Transcript
All right. Well, thank you, everyone, and welcome to another great session here at the 2022 Jefferies in person. At Global Healthcare Conference, we're commenting at how great it is to see so many -- some friends and clients and everyone in person.
I'm very happy to have up with me here on the stage, the Chief Medical Officer of Gilead Sciences, Merdad Parsey. Long time no see. Since I just saw you at ASCO and obviously, a lot of exciting things going on in oncology for you as well. And so we're going to go through some of that as well as hopefully some other things.
Questions & Answers
But maybe I would just take a step back and offer you the opportunity, since I think most people got the key highlights out of TRODELVY and ASCO, sort of a big picture question about how you feel about coming out of ASCO, your product profile for TRODELVY, how you guys feel about where we're going with that. Just make
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
